Conventional mood stabilizers and/or second-generation antipsychotic drugs in bipolar disorders: A population-based comparison of risk of treatment failure

Bipolar Disorder

Effects of a conventional mood stabilizer alone or in combination with second-generation antipsychotics on recurrence rate and discontinuation rate in bipolar I disorder in the maintenance phase: a systematic review and meta-analysis of randomized, placebo-controlled trials

Bipolar Disord

Kishi T, Sakuma K, Okuya M, Matsuda Y, Esumi S, Hashimoto Y, Hatano M, Miyake N, Miura I, Mishima K, Iwata N

doi: 10.1111/bdi.13053

Bipolar Disorder

Maintenance therapy with second generation antipsychotics for bipolar disorder - A systematic review and meta-analysis

J Affect Disord.

Lindström L, Lindström E, Nilsson M, Höistad M

doi: 10.1016/j.jad.2017.02.012.

Bipolar Disorder

Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder

Eur J Clin Pharmacol.

Grootens KP, Meijer A, Hartong EG, Doornbos B, Bakker PR, Al Hadithy A, Hoogerheide KN, Overmeire F, Marijnissen RM, Ruhe HG

doi: 10.1007/s00228-018-2517-2.

Bipolar Disorder

Pre-diagnostic and post-diagnostic psychopharmacological treatment of 16,288 patients with bipolar disorder

Bipolar Disord.

Köhler-Forsberg O, Gasse C, Hieronymus F, Petersen L, Christensen RH, Nierenberg AA, Østergaard SD

doi: 10.1111/bdi.12976.

DementiaPsychosis and Schizophrenia

Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials

Lancet Psychiatry.

Schneider-Thoma J, Efthimiou O, Huhn M, Krause M, Reichelt L, Röder H, Davis JM, Salanti G, Leucht S

doi: 10.1016/S2215-

Anxiety and DepressionBipolar Disorder

Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials

Lancet.

Dr Alexander McGirr, Paul A Vöhringer, S Nassir Ghaemi, Raymond W Lam, Prof Lakshmi N Yatham

Anxiety and Depression

Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment

Int J Neuropsychopharmacol.

Dold M, Bartova L, Kasper S

doi: 10.1093/ijnp/pyaa034.

RECOMMENDED

Anxiety and DepressionBipolar Disorder

Beyond Evidence-based Treatment of Bipolar Disorder: Rational Pragmatic Approaches to Management

Bipolar Disord.

Post RM, Yatham LN, Vieta E, Berk M, Nierenberg AA

doi: 10.1111/bdi.12813.

Anxiety and DepressionBipolar Disorder

Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment

Int J Bipolar Disord.

Pikalov A, Tsai J, Mao Y, Silva R, Cucchiaro J, Loebel A

doi: 10.1186/

Related content

Effects of a conventional mood stabilizer alone or in combination with second-generation antipsychotics on recurrence rate and discontinuation rate in bipolar I disorder in the maintenance phase: a systematic review and meta-analysis of randomized, placebo-controlled trials

Maintenance therapy with second generation antipsychotics for bipolar disorder - A systematic review and meta-analysis

Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder

Pre-diagnostic and post-diagnostic psychopharmacological treatment of 16,288 patients with bipolar disorder

Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials

Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials

Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment

Beyond Evidence-based Treatment of Bipolar Disorder: Rational Pragmatic Approaches to Management

Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment